Volume 86 Issue 42 | p. 23 | Concentrates
Issue Date: October 20, 2008

Sanofi-Aventis Joins With TB Drug Alliance

Department: Business

The Global Alliance for TB Drug Development and Sanofi-Aventis will collaborate on the discovery and development of drugs against tuberculosis. They will share information from their separate TB research efforts and discuss regulatory, clinical trial, and drug access strategies related to developing countries. The not-for-profit alliance has two TB drug candidates in clinical trials and 12 others in its pipeline. To support the alliance's work, the U.S. Agency for International Development has just awarded it up to $40 million over the next five years.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment